A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation

NCT02834936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung

Interventions

DRUG: pyrotinib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.